Hardware, Equipment & Parts
🏛 Recent congressional trades
“The 1.2% bump on the final trading day was a modest bounce within a clear downtrend -- TDY has lost 10.4% in the past month and sits 6.1% below its 50-day moving average. The selloff was macro-driven (spiking Treasury yields, Middle East tensions) rather than company-specific; Q2 beat estimates and guidance was raised, with a $5B funded backlog. At the 52-week midpoint, the risk/reward is balanced. Fundamentals remain solid, but wait for a clear re-cross of the 50-day line or a fresh catalyst before adding.”
Updated 09-14 03:22
The Fed held rates at 3.50%-3.75% in July 2026 but markets price in a potential hike at the Sep 15-16 FOMC meeting; elevated rates pressure growth stocks, though Teledyne's defense-driven revenue provides relative insulation from rate sensitivity.
European NATO defense spending surged 57% since 2021 to ~$520B in 2026, and Teledyne directly benefits via its $175M German framework agreement for PHOENIX-XR thermal sights and a $15.4M European drone contract, reinforcing its role in the multi-decade rearmament cycle.
Teledyne posted record Q2 2026 sales of $1,662.5M (+9.8% YoY) and Non-GAAP EPS of $6.28 (+20.8%), while the $1.1B all-cash acquisition of Varex Imaging expands its medical X-ray portfolio without equity dilution—strengthening long-term growth visibility.
TDY has declined 13.3% in the past 4 weeks and now trades below both its 50-day ($642.68) and 200-day ($615.96) moving averages; however, analyst consensus remains Moderate Buy with a mean price target of ~$695-$721, suggesting the pullback may be overdone.
Teledyne Qioptiq received the first option from Germany for additional PHOENIX-XR cooled thermal weapon sights valued at over $21M (Sep 4), and secured a $15.4M contract to support European drone dominance (Sep 9)—both underscoring strong momentum in international defense orders.
Updated 09-14 03:23
Updated 09-14 03:22